Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Cash from Financing Activities: 2021-2024

Historic Cash from Financing Activities for Biofrontera (BFRI) over the last 1 years, with Dec 2024 value amounting to $4.0 million.

  • Biofrontera's Cash from Financing Activities fell 39.68% to $4.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $14.8 million, marking a year-over-year decrease of 73.40%. This contributed to the annual value of $14.8 million for FY2024, which is 76.38% up from last year.
  • Latest data reveals that Biofrontera reported Cash from Financing Activities of $4.0 million as of Q4 2024, which was up 1,459.06% from -$298,000 recorded in Q3 2024.
  • Over the past 5 years, Biofrontera's Cash from Financing Activities peaked at $43.8 million during Q4 2021, and registered a low of -$298,000 during Q3 2024.
  • Moreover, its 3-year median value for Cash from Financing Activities was $4.6 million (2022), whereas its average is $3.8 million.
  • In the last 5 years, Biofrontera's Cash from Financing Activities spiked by 3,926.45% in 2022 and then plummeted by 150.42% in 2024.
  • Quarterly analysis of 4 years shows Biofrontera's Cash from Financing Activities stood at $43.8 million in 2021, then skyrocketed by 3,926.45% to $4.6 million in 2022, then slumped by 87.24% to $6.7 million in 2023, then tumbled by 39.68% to $4.0 million in 2024.
  • Its last three reported values are $4.0 million in Q4 2024, -$298,000 for Q3 2024, and $5.3 million during Q2 2024.